Department of Hematology and Medical Oncology

News

A study led by Winship Cancer Institute of Emory University offers new insight into what causes resistance to the non-small cell lung cancer medication osimertinib that may prove valuable in developing more effective therapies.

The International Cardio-Oncology Society has designated Winship Cancer Institute of Emory University a gold-level Cardio-Oncology “Center of Excellence,” one of fewer than 35 gold-level centers worldwide.

The New England Journal of Medicine reports a study co-led by Ajay Nooka, MD, MPH, at Winship Cancer Institute of Emory University of a combination therapy potentially benefiting people with relapsed multiple myeloma.

Events

Loading Events...